US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

EyePoint

5.91

+0.06001.03%

Pre-market: 5.940.0300+0.51%08:00 EDT

Volume:497.44K

Turnover:2.93M

Market Cap:406.68M

PE:-2.44

High:6.00

Open:5.97

Low:5.78

Close:5.85

Loading ...

Overview Company News Filings

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Foghorn Therapeutics (FHTX) Soars 11.4%: Is Further Upside Left in the Stock?

EyePoint Pharmaceuticals Is Maintained at Buy by Chardan Capital

BUZZ-EyePoint Pharma rises on eye disease drug trial data

EyePoint Pharmaceuticals: An Undervalued Opportunity Amid Market Overreaction and Financing Concerns

EyePoint's Phase 2 Trial of Duravyu to Treat Diabetic Macular Edema Meets Endpoints; Shares Still Slump Pre-Bell

MT Newswires Live

Collegium Pharmaceutical Expands Board with Nancy Lurker

Collegium appoints Nancy Lurker to board of directors

Top Premarket Decliners

MT Newswires Live

EyePoint announces Phase 2 VERONA trial met primary endpoint

EyePoint Announces Positive Six-Month Results for the Phase 2 Verona Clinical Trial of Duravyu™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints

THOMSON REUTERS

EyePoint Pharmaceuticals Inc - No Duravyu-Related Ocular or Systemic Saes Reported

THOMSON REUTERS

EyePoint Pharmaceuticals Inc - Primary Endpoint Achieved by Both Duravyu Doses

THOMSON REUTERS

EyePoint Pharmaceuticals Inc: Phase 3 Non-Inferiority Pivotal Program Initiation Anticipated by End of 2025 -

THOMSON REUTERS

EyePoint Announces Positive Six-Month Results for the Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints

EyePoint to Present at Guggenheim SMID Cap Biotech Conference

EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals Inc: Cash Runway Into 2027 Beyond Topline Duravyu Phase 3 Wet Amd Data Expected in 2026

THOMSON REUTERS

EyePoint Pharmaceuticals: Full Data for Phase 2 Verona Clinical Trial of Duravyu in Dme Expected in 1Q 2025

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EYPT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EYPT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYPT\",,,,,undefined,":{"symbol":"EYPT","market":"US","secType":"STK","nameCN":"EyePoint","latestPrice":5.91,"timestamp":1747166400000,"preClose":5.85,"halted":0,"volume":497440,"hourTrading":{"tag":"盘前","latestPrice":5.94,"preClose":5.91,"latestTime":"08:00 EDT","volume":838,"amount":4977.72,"timestamp":1747224000233},"delay":0,"floatShares":43630232,"shares":68811736,"eps":-2.425671,"marketStatus":"Pre-Mkt","change":0.06,"latestTime":"05-14 08:38:19 EDT","open":5.97,"high":6,"low":5.78,"amount":2933834.96048,"amplitude":0.037607,"askPrice":6.51,"askSize":100,"bidPrice":5.32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.425671,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1747229400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.91,"preHourTrading":{"tag":"盘前","latestPrice":5.94,"preClose":5.91,"latestTime":"08:00 EDT","volume":838,"amount":4977.72,"timestamp":1747224000233},"postHourTrading":{"tag":"盘后","latestPrice":5.9599,"preClose":5.91,"latestTime":"18:37 EDT","volume":17446,"amount":103118.335,"timestamp":1747175845690},"volumeRatio":0.7964802695958133,"impliedVol":1.1965,"impliedVolPercentile":0.8876},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYPT\",,,,,undefined,":{"symbol":"EYPT","floatShares":43630232,"roa":"-29.16%","roe":"-53.54%","lyrEps":-2.324594,"volumeRatio":0.7964802695958133,"shares":68811736,"dividePrice":0,"high":6,"amplitude":0.037607,"preClose":5.85,"low":5.78,"week52Low":3.91,"pbRate":"1.36","psRate":"7.26","week52High":13.985,"institutionHeld":0.3776,"latestPrice":5.91,"eps":-2.425671,"divideRate":0,"volume":497440,"delay":0,"ttmEps":-2.425671,"open":5.97,"prevYearClose":7.45,"prevWeekClose":5.81,"prevMonthClose":6.82,"prevQuarterClose":5.42,"fiveDayClose":6.25,"twentyDayClose":5.71,"sixtyDayClose":6.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EYPT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512941434","title":"EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2512941434","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512941434?lang=en_us&edition=fundamental","pubTime":"2025-02-17 20:00","pubTimestamp":1739793600,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Feb. 17, 2025  -- EyePoint Pharmaceuticals, Inc. , a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eyepoint-pharmaceuticals-reports-inducement-grants-120000517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4566","BK4529","TQQQ","LU0082616367.USD","QLD","BK4007","BK4585","LU1064131342.USD","LU1316542783.SGD","LU2360106780.USD","LU1951200564.SGD","LU0823434740.USD","USAW.SI","LU1923623000.USD","SQQQ","EYPT","IE0004445239.USD","BK4532","IE00BKPKM429.USD","LU0889565833.HKD","LU0109394709.USD","LU0979878070.USD","LU2250418816.HKD","IE00B5949003.HKD","NVIW.SI","LU1880398554.USD","NQmain","LU1880398471.USD","BK4112","BK4588","LU0198837287.USD","NDAQ","BK4573","BK4554","LU0823421416.USD","LU1988902786.USD","IE0009356076.USD","LU0109392836.USD","LU2264538146.SGD",".IXIC","LU0081259029.USD","USJW.SI","PSQ","MNQmain","TSYW.SI","QID","LU0642271901.SGD","LU0823421333.USD"],"gpt_icon":1},{"id":"2510339044","title":"Foghorn Therapeutics (FHTX) Soars 11.4%: Is Further Upside Left in the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2510339044","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510339044?lang=en_us&edition=fundamental","pubTime":"2025-02-11 22:24","pubTimestamp":1739283840,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics Inc.  shares ended the last trading session 11.4% higher at $5.29. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.5% gain over the past four weeks.Last month, the company outlined key strategic objectives and several pipeline goals for 2025. The growing optimism related to Foghorn’s product candidates, which are being developed to treat a wide range of cancers, might have driven the recent share price rally.This company is expected to post quarterly loss of $0.29 per share in its upcoming report, which represents a year-over-year change of +49.1%. Revenues are expected to be $11.72 million, up 103.1% from the year-ago quarter.Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.To read","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/foghorn-therapeutics-fhtx-soars-11-142400340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EYPT","BK4139","LU0889565916.HKD","BK4588","FHTX","LU0320765992.SGD","BK4007","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"2509727644","title":"EyePoint Pharmaceuticals Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2509727644","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509727644?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:41","pubTimestamp":1738849260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EYPT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 06, 2025 08:41 ET (13:41 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT"],"gpt_icon":0},{"id":"2509280144","title":"BUZZ-EyePoint Pharma rises on eye disease drug trial data","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280144","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509280144?lang=en_us&edition=fundamental","pubTime":"2025-02-05 23:18","pubTimestamp":1738768734,"startTime":"0","endTime":"0","summary":"BUZZ-EyePoint Pharma rises on eye disease drug trial data** Shares of drugmaker EyePoint Pharmaceuticals EYPT.O rise ~11% to $8.47** EYPT says its drug, Duravyu, met the main goal in mid-stage trial for the treatment of diabetic macular edema, a condition where fluid builds up in the central part of the retina due to damaged blood vessels** The main goal was to evaluate if the drug could reduce the frequency of injections needed to treat the condition compared to the standard treatment, aflibercept** 2.7 mg dose of Duravyu helped 73% of patients avoid extra injections, compared to 50% of patients treated with aflibercept - EYPT** Co plans to initiate a late-stage non-inferiority trial for the drug by the end of 2025** EYPT fell ~67% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nL4N3OW1PY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0320765992.SGD","EYPT","LU0889565916.HKD","LU0109394709.USD","BK4007","BK4588"],"gpt_icon":0},{"id":"2509628463","title":"EyePoint Pharmaceuticals: An Undervalued Opportunity Amid Market Overreaction and Financing Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2509628463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509628463?lang=en_us&edition=fundamental","pubTime":"2025-02-05 22:25","pubTimestamp":1738765526,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Debanjana Chatterjee reiterated a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report) today and set a price target...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/eyepoint-pharmaceuticals-an-undervalued-opportunity-amid-market-overreaction-and-financing-concerns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/eyepoint-pharmaceuticals-an-undervalued-opportunity-amid-market-overreaction-and-financing-concerns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4007","EYPT","BK4585","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2509281510","title":"EyePoint's Phase 2 Trial of Duravyu to Treat Diabetic Macular Edema Meets Endpoints; Shares Still Slump Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2509281510","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509281510?lang=en_us&edition=fundamental","pubTime":"2025-02-05 22:12","pubTimestamp":1738764760,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals  reported six-month results from a phase 2 trial of Duravyu to treat diabetic macular edema that met primary and secondary endpoints, but its shares still slumped in premarket trading.The company said the trial demonstrated \"clinically meaningful outcomes,\" such as continued safety with no Duravyu-related ocular or systemic serious adverse events, and an early and sustained improvement in vision and anatomical control.EyePoint shares were 23% lower in premarket trading","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EYPT","BK4585","BK4588","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","BK4007"],"gpt_icon":0},{"id":"2509528687","title":"Collegium Pharmaceutical Expands Board with Nancy Lurker","url":"https://stock-news.laohu8.com/highlight/detail?id=2509528687","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509528687?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:29","pubTimestamp":1738762173,"startTime":"0","endTime":"0","summary":"Collegium Pharmaceutical ( ($COLL) ) has issued an announcement. On February 3, 2025, Collegium Pharmaceutical, Inc. announced the expansion of its...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/collegium-pharmaceutical-expands-board-with-nancy-lurker?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/collegium-pharmaceutical-expands-board-with-nancy-lurker?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4588","LU0320765992.SGD","BK4007","LU0109394709.USD","BK4585","EYPT","COLL"],"gpt_icon":0},{"id":"2509863842","title":"Collegium appoints Nancy Lurker to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2509863842","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509863842?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:25","pubTimestamp":1738761946,"startTime":"0","endTime":"0","summary":"Collegium Pharmaceutical (COLL) announced the appointment of Nancy Lurker to its Board of Directors, effective February 4, 2025. Lurker most recent...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/collegium-appoints-nancy-lurker-to-board-of-directors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/collegium-appoints-nancy-lurker-to-board-of-directors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","COLL","LU0889565916.HKD","EYPT","BK4585","BK4588","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2509283779","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2509283779","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509283779?lang=en_us&edition=fundamental","pubTime":"2025-02-05 20:56","pubTimestamp":1738760194,"startTime":"0","endTime":"0","summary":"Grupo Simec  shares slumped 58% pre-bell Wednesday, reversing from Tuesday's rally.EyePoint Pharmaceuticals  shares retreated 26% following a 6.3% increase in the previous session.FMC Corporation  shares fell 23%, a day after the company issued guidance for Q1 and 2025 that trailed analysts' projections.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SIM","LU0889565916.HKD","LU0385154629.USD","LU0471298777.SGD","BK4588","LU0320765992.SGD","EYPT","BK4007","BK4006","LU0109394709.USD","BK4545","BK4585","BK4093","FMC"],"gpt_icon":0},{"id":"2509073934","title":"EyePoint announces Phase 2 VERONA trial met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2509073934","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509073934?lang=en_us&edition=fundamental","pubTime":"2025-02-05 20:05","pubTimestamp":1738757124,"startTime":"0","endTime":"0","summary":"EyePoint (EYPT) Pharmaceuticals announced positive six-month results for the ongoing Phase 2 VERONA clinical trial evaluating DURAVYU, an investiga...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eyepoint-announces-phase-2-verona-trial-met-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eyepoint-announces-phase-2-verona-trial-met-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","EYPT","LU0320765992.SGD","LU0889565916.HKD","BK4588","LU0109394709.USD","BK4007"],"gpt_icon":0},{"id":"2509540299","title":"EyePoint Announces Positive Six-Month Results for the Phase 2 Verona Clinical Trial of Duravyu™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2509540299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509540299?lang=en_us&edition=fundamental","pubTime":"2025-02-05 20:00","pubTimestamp":1738756802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nTUAHTTQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU0109394709.USD","BK4585","BK4588","BK4007","EYPT","LU0889565916.HKD"],"gpt_icon":0},{"id":"2509402945","title":"EyePoint Pharmaceuticals Inc - No Duravyu-Related Ocular or Systemic Saes Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2509402945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509402945?lang=en_us&edition=fundamental","pubTime":"2025-02-05 20:00","pubTimestamp":1738756802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nTUAHTTQN:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU0109394709.USD","BK4585","LU0320765992.SGD","LU0889565916.HKD","EYPT","BK4588"],"gpt_icon":0},{"id":"2509402673","title":"EyePoint Pharmaceuticals Inc - Primary Endpoint Achieved by Both Duravyu Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2509402673","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509402673?lang=en_us&edition=fundamental","pubTime":"2025-02-05 20:00","pubTimestamp":1738756802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nTUAHTTQN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","BK4588","LU0320765992.SGD","BK4007","LU0109394709.USD","BK4585","EYPT"],"gpt_icon":0},{"id":"2509402629","title":"EyePoint Pharmaceuticals Inc: Phase 3 Non-Inferiority Pivotal Program Initiation Anticipated by End of 2025 -","url":"https://stock-news.laohu8.com/highlight/detail?id=2509402629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509402629?lang=en_us&edition=fundamental","pubTime":"2025-02-05 20:00","pubTimestamp":1738756802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nTUAHTTQN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYPT","BK4585","BK4588","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","BK4007"],"gpt_icon":0},{"id":"2509402196","title":"EyePoint Announces Positive Six-Month Results for the Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2509402196","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509402196?lang=en_us&edition=fundamental","pubTime":"2025-02-05 20:00","pubTimestamp":1738756800,"startTime":"0","endTime":"0","summary":"- Primary endpoint achieved by both DURAVYU doses  with extended time to first supplemental injection versus aflibercept control –。“We are extremely pleased to report these highly positive VERONA results that demonstrate 2.7mg DURAVYU immediately and meaningfully improves both visual acuity and anatomy in DME patients with a superior dosing interval and excellent safety. This underscores the potential of DURAVYU to be a best-in-class treatment for patients,” said Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint. “DME is the leading cause of vision loss in working age adults and the second largest market in retinal diseases after wet age-related macular degeneration . The data from the VERONA trial demonstrate that after a single DURAVYU 2.7mg treatment there was an early and maintained improvement in both BCVA and retinal thickening as measured by OCT throughout the six-month trial, demonstrating the differentiated profile of DURAVYU with immediate bioavailability ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eyepoint-announces-positive-six-month-120000981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","BK4566","BK4529","IVT","LU1242518931.SGD","LU1852331112.SGD","BK4007","LU1316542783.SGD","LU1989764664.SGD","LU2458330169.SGD","LU1242518857.USD","LU1951200564.SGD","LU0823434740.USD","LU1923623000.USD","EYPT","LU0889565833.HKD","BK4543","LU0109394709.USD","LU0979878070.USD","LU1803068979.SGD","LU2458330243.SGD","LU2250418816.HKD","BK4141","GFS","LU0719512351.SGD","LU1880398554.USD","LU1303367103.USD","LU0127658192.USD","LU1880398471.USD","BK4588","LU0198837287.USD","CST","LU0056508442.USD","BK4573","BK4554","BK4231","IE0009356076.USD","LU0109392836.USD","LU1988902786.USD","LU2054465674.USD","LU2264538146.SGD","LU0823434583.USD","LU0081259029.USD","LU0390134368.USD","IE00BMPRXN33.USD","IE00BMPRXR70.SGD","LU0642271901.SGD","LU0823421333.USD","LU1951198990.SGD"],"gpt_icon":1},{"id":"2507642861","title":"EyePoint to Present at Guggenheim SMID Cap Biotech Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2507642861","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507642861?lang=en_us&edition=fundamental","pubTime":"2025-01-30 20:00","pubTimestamp":1738238400,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Jan. 30, 2025  -- EyePoint Pharmaceuticals, Inc. , a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference on Thursday, February 6, 2025 at 9:30 a.m. ET.Pipeline programs include EYP-2301, a TIE-2 agonist, razuprotafib, formulated in Durasert Eto potentially improve outcomes in serious retinal diseases. The proven Durasertdrug delivery technology has been safely administered to thousands of patient eyes across fourU.S.FDA approved products.EyePoint Pharmaceuticalsis headquartered inWatertown, Massachusetts.DURAVYU has been conditionally accepted by the FDA as the proprietary name for EYP-1901. DURAVYU is an investigational product; it has not been approved by the FDA. FDA approval and the timeline for potential ap","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eyepoint-present-guggenheim-smid-cap-120000292.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4573","BK4512","BK4575","LU0823421416.USD","LU1316542783.SGD","LU1303367103.USD","LU1951200564.SGD","LU1951198990.SGD","BK4011","LU1923623000.USD","LU1242518857.USD","LU0390134368.USD","LU1803068979.SGD","BK4529","BK4566","LU1242518931.SGD","LU0320765992.SGD","LU0642271901.SGD","LU1064131342.USD","IE0009356076.USD","LU1852331112.SGD","SMID","LU0081259029.USD","IE00BMPRXN33.USD","LU0109394709.USD","EYPT","LU2250418816.HKD","LU2054465674.USD","LU2264538146.SGD","LU0082616367.USD","LU2098885051.SGD","LU0109392836.USD","LU0198837287.USD","LU2458330243.SGD","IE00B5949003.HKD","LU0056508442.USD","LU0889565916.HKD","BK4534","BK4141","LU0823434740.USD","IE0004445239.USD","LU0889565833.HKD","LU0719512351.SGD","BK4532","LU1880398471.USD","LU1988902786.USD","BK4588","LU0979878070.USD"],"gpt_icon":1},{"id":"2503982459","title":"EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503982459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503982459?lang=en_us&edition=fundamental","pubTime":"2025-01-16 20:00","pubTimestamp":1737028800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250116:nTUA5LGL9K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU0109394709.USD","LU0889565916.HKD","EYPT","BK4585","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2503935669","title":"EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503935669","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503935669?lang=en_us&edition=fundamental","pubTime":"2025-01-16 20:00","pubTimestamp":1737028800,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Jan.  16, 2025  (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of pat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/16/3010670/0/en/EyePoint-Pharmaceuticals-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0127658192.USD","LU1852331112.SGD","LU1951200564.SGD","NDAQ","LU0390134368.USD","USAW.SI","BK4588","QLD","TQQQ","LU2210150020.SGD","PSQ","IE00BGHQF748.EUR","BK4543","LU1923623000.USD","MNQmain","LU2098885051.SGD","LU1803068979.SGD","LU0823421333.USD","TSYW.SI","BK4534","IE0004445239.USD","NVIW.SI","QID","LU1242518931.SGD","LU0082616367.USD","BK4573","LU1242518857.USD","IE00B64PRP62.GBP","LU0109392836.USD","LU0056508442.USD","LU2458330169.SGD",".IXIC","LU2360106780.USD","SQQQ","LU0889565916.HKD","IE0009356076.USD","LU1316542783.SGD","NQmain","LU1880398554.USD","BK4575","IE00BMPRXN33.USD","USJW.SI","EYPT","IE00B3QW5Z07.USD","LU0823434583.USD","BK4585","LU1989764664.SGD","LU0198837287.USD"],"gpt_icon":1},{"id":"2503130807","title":"EyePoint Pharmaceuticals Inc: Cash Runway Into 2027 Beyond Topline Duravyu Phase 3 Wet Amd Data Expected in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2503130807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503130807?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:07","pubTimestamp":1736770034,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O90PM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYPT","BK4585","LU0889565916.HKD","BK4007","LU0320765992.SGD","LU0109394709.USD","BK4588"],"gpt_icon":0},{"id":"2503079308","title":"EyePoint Pharmaceuticals: Full Data for Phase 2 Verona Clinical Trial of Duravyu in Dme Expected in 1Q 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503079308","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503079308?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:07","pubTimestamp":1736770034,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O90PM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","EYPT","BK4585","BK4007","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":83,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EYPT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"EYPT","fiscalQuarterEnding":"2025/03","expectedEps":-0.65,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":-0.65},{"market":"US","date":"2025-03-05","symbol":"EYPT","fiscalQuarterEnding":"2024/12","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741150800000,"reportTimeType":"pre","actualEps":-0.64},{"market":"US","date":"2024-11-07","symbol":"EYPT","fiscalQuarterEnding":"2024/09","expectedEps":-0.48,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.54},{"market":"US","date":"2024-08-07","symbol":"EYPT","fiscalQuarterEnding":"2024/06","expectedEps":-0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2024-05-08","symbol":"EYPT","fiscalQuarterEnding":"2024/03","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-0.55}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EYPT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EYPT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3077,"buy":0.6923,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6923,"analysts":13,"updateTime":1736481600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EYPT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EYPT","date":"2025-05-13","current":-2.742512,"percent":0.682114,"low":-17.174537,"twenty":-7.275504,"median":-4.857083,"eighty":-2.021433,"high":-0.764844,"avg":-5.087871,"sd":3.282244,"marketCap":402548655},"quantilePoints":[{"date":"2020-05-15","current":-1.967188,"twenty":-4.129491,"median":-2.673684,"eighty":8.313039,"marketCap":99793464},{"date":"2020-05-22","current":-2.163906,"twenty":-4.053534,"median":-2.669984,"eighty":8.313039,"marketCap":109772810},{"date":"2020-05-29","current":-2.114727,"twenty":-4.031446,"median":-2.655853,"eighty":8.313039,"marketCap":107277973},{"date":"2020-06-05","current":-2.020056,"twenty":-3.86974,"median":-2.63576,"eighty":8.313039,"marketCap":102475413},{"date":"2020-06-12","current":-2.030138,"twenty":-3.770824,"median":-2.625354,"eighty":8.313039,"marketCap":102986854},{"date":"2020-06-19","current":-2.178906,"twenty":-3.703766,"median":-2.608156,"eighty":8.313039,"marketCap":110533735},{"date":"2020-06-26","current":-1.940139,"twenty":-3.621507,"median":-2.601703,"eighty":8.313039,"marketCap":98421303},{"date":"2020-07-02","current":-1.788911,"twenty":-3.593653,"median":-2.583964,"eighty":8.313039,"marketCap":90749681},{"date":"2020-07-10","current":-1.844238,"twenty":-3.568662,"median":-2.560659,"eighty":8.313039,"marketCap":93556372},{"date":"2020-07-17","current":-1.797518,"twenty":-3.557498,"median":-2.53573,"eighty":8.313039,"marketCap":91186277},{"date":"2020-07-24","current":-1.794075,"twenty":-3.517895,"median":-2.520652,"eighty":8.313039,"marketCap":91011639},{"date":"2020-07-31","current":-1.745879,"twenty":-3.498799,"median":-2.498114,"eighty":8.313039,"marketCap":88566699},{"date":"2020-08-07","current":-1.679767,"twenty":-3.461955,"median":-2.481381,"eighty":8.313039,"marketCap":87651942},{"date":"2020-08-14","current":-1.463797,"twenty":-3.43868,"median":-2.45699,"eighty":8.313039,"marketCap":76382406},{"date":"2020-08-21","current":-1.619296,"twenty":-3.420624,"median":-2.443093,"eighty":8.313039,"marketCap":84496472},{"date":"2020-08-28","current":-1.346933,"twenty":-3.40898,"median":-2.436189,"eighty":8.313039,"marketCap":70284335},{"date":"2020-09-04","current":-1.175837,"twenty":-3.391841,"median":-2.423704,"eighty":8.313039,"marketCap":61356359},{"date":"2020-09-11","current":-1.207513,"twenty":-3.382893,"median":-2.419615,"eighty":8.313039,"marketCap":63009224},{"date":"2020-09-18","current":-1.417964,"twenty":-3.36447,"median":-2.417412,"eighty":8.313039,"marketCap":73990760},{"date":"2020-09-25","current":-1.352693,"twenty":-3.340822,"median":-2.404314,"eighty":8.313039,"marketCap":70584856},{"date":"2020-10-02","current":-1.218791,"twenty":-3.319236,"median":-2.397965,"eighty":8.313039,"marketCap":63597744},{"date":"2020-10-09","current":-1.350942,"twenty":-3.303186,"median":-2.384452,"eighty":8.313039,"marketCap":70493486},{"date":"2020-10-16","current":-1.23083,"twenty":-3.283504,"median":-2.369413,"eighty":8.313039,"marketCap":64225934},{"date":"2020-10-23","current":-1.175454,"twenty":-3.25648,"median":-2.362921,"eighty":8.313039,"marketCap":61336369},{"date":"2020-10-30","current":-0.959078,"twenty":-3.240625,"median":-2.348435,"eighty":8.313039,"marketCap":50045661},{"date":"2020-11-06","current":-1.324675,"twenty":-3.216801,"median":-2.346145,"eighty":8.313039,"marketCap":53430757},{"date":"2020-11-13","current":-1.590108,"twenty":-3.216801,"median":-2.346145,"eighty":-0.9982,"marketCap":64137000},{"date":"2020-11-20","current":-1.543141,"twenty":-3.216801,"median":-2.346145,"eighty":-1.171499,"marketCap":62242598},{"date":"2020-11-27","current":-1.919231,"twenty":-3.216801,"median":-2.346145,"eighty":-1.200272,"marketCap":77412169},{"date":"2020-12-04","current":-1.842732,"twenty":-3.216801,"median":-2.346145,"eighty":-1.222823,"marketCap":74326589},{"date":"2020-12-11","current":-1.601713,"twenty":-3.216801,"median":-2.346145,"eighty":-1.241396,"marketCap":64605100},{"date":"2020-12-18","current":-1.740503,"twenty":-3.216801,"median":-2.346145,"eighty":-1.260673,"marketCap":70203200},{"date":"2020-12-24","current":-1.871791,"twenty":-3.216801,"median":-2.346145,"eighty":-1.277689,"marketCap":75498700},{"date":"2020-12-31","current":-2.468214,"twenty":-3.216801,"median":-2.346145,"eighty":-1.288397,"marketCap":99555400},{"date":"2021-01-08","current":-4.654737,"twenty":-3.240625,"median":-2.348896,"eighty":-1.298508,"marketCap":187748803},{"date":"2021-01-15","current":-4.916121,"twenty":-3.25648,"median":-2.365535,"eighty":-1.340948,"marketCap":198291759},{"date":"2021-01-22","current":-4.456923,"twenty":-3.283504,"median":-2.369413,"eighty":-1.352343,"marketCap":179770001},{"date":"2021-01-29","current":-5.042176,"twenty":-3.301349,"median":-2.384452,"eighty":-1.389848,"marketCap":203376163},{"date":"2021-02-05","current":-9.458126,"twenty":-3.31529,"median":-2.397965,"eighty":-1.422978,"marketCap":381493495},{"date":"2021-02-12","current":-9.493708,"twenty":-3.337373,"median":-2.404314,"eighty":-1.474613,"marketCap":382928703},{"date":"2021-02-19","current":-9.436817,"twenty":-3.354884,"median":-2.417412,"eighty":-1.493755,"marketCap":380633999},{"date":"2021-02-26","current":-7.687414,"twenty":-3.372729,"median":-2.418057,"eighty":-1.53113,"marketCap":310071856},{"date":"2021-03-05","current":-5.964997,"twenty":-3.391081,"median":-2.423704,"eighty":-1.551042,"marketCap":270775053},{"date":"2021-03-12","current":-7.097677,"twenty":-3.408419,"median":-2.436237,"eighty":-1.575196,"marketCap":322191934},{"date":"2021-03-19","current":-6.679794,"twenty":-3.417351,"median":-2.443093,"eighty":-1.593719,"marketCap":303222561},{"date":"2021-03-26","current":-6.318895,"twenty":-3.431949,"median":-2.45699,"eighty":-1.616992,"marketCap":286839920},{"date":"2021-04-01","current":-6.844414,"twenty":-3.459804,"median":-2.473797,"eighty":-1.642233,"marketCap":310695344},{"date":"2021-04-09","current":-6.33789,"twenty":-3.476049,"median":-2.49355,"eighty":-1.660834,"marketCap":287702164},{"date":"2021-04-16","current":-5.93267,"twenty":-3.509728,"median":-2.517525,"eighty":-1.676541,"marketCap":269307620},{"date":"2021-04-23","current":-6.173269,"twenty":-3.546897,"median":-2.53573,"eighty":-1.693188,"marketCap":280229381},{"date":"2021-04-30","current":-6.768436,"twenty":-3.561832,"median":-2.550655,"eighty":-1.703972,"marketCap":307246367},{"date":"2021-05-07","current":-6.290831,"twenty":-3.585661,"median":-2.577992,"eighty":-1.725619,"marketCap":279941966},{"date":"2021-05-14","current":-5.728919,"twenty":-3.617777,"median":-2.601703,"eighty":-1.736213,"marketCap":254936883},{"date":"2021-05-21","current":-6.038939,"twenty":-3.688868,"median":-2.606167,"eighty":-1.747012,"marketCap":268732791},{"date":"2021-05-28","current":-6.34896,"twenty":-3.758867,"median":-2.625354,"eighty":-1.757896,"marketCap":282528699},{"date":"2021-06-04","current":-5.916223,"twenty":-3.833087,"median":-2.633765,"eighty":-1.757896,"marketCap":263271911},{"date":"2021-06-11","current":-6.13582,"twenty":-3.971601,"median":-2.648063,"eighty":-1.769753,"marketCap":273044012},{"date":"2021-06-18","current":-6.168114,"twenty":-4.031446,"median":-2.667311,"eighty":-1.776996,"marketCap":274481086},{"date":"2021-06-25","current":-6.148738,"twenty":-4.076439,"median":-2.672658,"eighty":-1.784872,"marketCap":273618842},{"date":"2021-07-02","current":-5.696625,"twenty":-4.139513,"median":-2.68536,"eighty":-1.794961,"marketCap":253499809},{"date":"2021-07-09","current":-5.199301,"twenty":-4.174872,"median":-2.694091,"eighty":-1.80403,"marketCap":231368873},{"date":"2021-07-16","current":-4.960326,"twenty":-4.238237,"median":-2.704008,"eighty":-1.826995,"marketCap":220734528},{"date":"2021-07-23","current":-5.322017,"twenty":-4.294025,"median":-2.711822,"eighty":-1.843597,"marketCap":236829754},{"date":"2021-07-30","current":-5.309099,"twenty":-4.346909,"median":-2.719962,"eighty":-1.858853,"marketCap":236254924},{"date":"2021-08-06","current":-6.37565,"twenty":-4.370091,"median":-2.731788,"eighty":-1.874633,"marketCap":264972003},{"date":"2021-08-13","current":-7.164818,"twenty":-4.402389,"median":-2.736518,"eighty":-1.891961,"marketCap":297769841},{"date":"2021-08-20","current":-7.06098,"twenty":-4.441277,"median":-2.741305,"eighty":-1.914408,"marketCap":293454336},{"date":"2021-08-27","current":-6.964065,"twenty":-4.472799,"median":-2.743614,"eighty":-1.930259,"marketCap":289426531},{"date":"2021-09-03","current":-7.628628,"twenty":-4.546098,"median":-2.75544,"eighty":-1.941719,"marketCap":317045763},{"date":"2021-09-10","current":-7.102515,"twenty":-4.61979,"median":-2.759953,"eighty":-1.956547,"marketCap":295180538},{"date":"2021-09-17","current":-7.642473,"twenty":-4.694611,"median":-2.760901,"eighty":-1.971028,"marketCap":317621164},{"date":"2021-09-24","current":-8.113205,"twenty":-4.731269,"median":-2.77201,"eighty":-1.988007,"marketCap":337184786},{"date":"2021-10-01","current":-7.760156,"twenty":-4.841039,"median":-2.78384,"eighty":-1.998647,"marketCap":322512069},{"date":"2021-10-08","current":-7.137128,"twenty":-4.919907,"median":-2.790917,"eighty":-2.015619,"marketCap":296619040},{"date":"2021-10-15","current":-7.919374,"twenty":-4.938321,"median":-2.79725,"eighty":-2.019761,"marketCap":329129177},{"date":"2021-10-22","current":-8.313958,"twenty":-4.971427,"median":-2.804116,"eighty":-2.02816,"marketCap":345528096},{"date":"2021-10-29","current":-7.940141,"twenty":-5.098544,"median":-2.833605,"eighty":-2.028584,"marketCap":329992278},{"date":"2021-11-05","current":-7.455146,"twenty":-5.185586,"median":-2.834547,"eighty":-2.038548,"marketCap":405962535},{"date":"2021-11-12","current":-7.40231,"twenty":-5.288363,"median":-2.838221,"eighty":-2.041297,"marketCap":403085408},{"date":"2021-11-19","current":-10.730609,"twenty":-5.348044,"median":-2.838221,"eighty":-2.041297,"marketCap":584324577},{"date":"2021-11-26","current":-10.288687,"twenty":-5.475735,"median":-2.838221,"eighty":-2.041297,"marketCap":560260166},{"date":"2021-12-03","current":-9.043837,"twenty":-5.543465,"median":-2.838221,"eighty":-2.041297,"marketCap":492473092},{"date":"2021-12-10","current":-9.050061,"twenty":-5.631762,"median":-2.838221,"eighty":-2.041297,"marketCap":492812027},{"date":"2021-12-17","current":-8.502327,"twenty":-5.718585,"median":-2.850463,"eighty":-2.041297,"marketCap":462985715},{"date":"2021-12-23","current":-8.43386,"twenty":-5.736973,"median":-2.850463,"eighty":-2.041297,"marketCap":459257426},{"date":"2021-12-31","current":-7.618483,"twenty":-5.783171,"median":-2.850463,"eighty":-2.041297,"marketCap":414856892},{"date":"2022-01-07","current":-8.782418,"twenty":-5.864553,"median":-2.850463,"eighty":-2.041984,"marketCap":478237807},{"date":"2022-01-14","current":-6.180681,"twenty":-5.916223,"median":-2.850463,"eighty":-2.041984,"marketCap":336562822},{"date":"2022-01-21","current":-5.439995,"twenty":-5.918806,"median":-2.850463,"eighty":-2.041984,"marketCap":296229513},{"date":"2022-01-28","current":-5.40265,"twenty":-5.918806,"median":-2.850463,"eighty":-2.041984,"marketCap":294195901},{"date":"2022-02-04","current":-5.813451,"twenty":-5.931903,"median":-2.850463,"eighty":-2.041984,"marketCap":316565635},{"date":"2022-02-11","current":-6.224251,"twenty":-5.976705,"median":-2.850463,"eighty":-2.041984,"marketCap":338935370},{"date":"2022-02-18","current":-5.639172,"twenty":-6.042095,"median":-2.850463,"eighty":-2.041984,"marketCap":307075445},{"date":"2022-02-25","current":-5.801002,"twenty":-6.042095,"median":-2.850463,"eighty":-2.041984,"marketCap":315887764},{"date":"2022-03-04","current":-6.637487,"twenty":-6.076834,"median":-2.850463,"eighty":-2.041984,"marketCap":387742063},{"date":"2022-03-11","current":-7.652837,"twenty":-6.099766,"median":-2.850463,"eighty":-2.041984,"marketCap":447055753},{"date":"2022-03-18","current":-7.447927,"twenty":-6.135388,"median":-2.850467,"eighty":-2.041984,"marketCap":435085578},{"date":"2022-03-25","current":-7.401305,"twenty":-6.148738,"median":-2.850472,"eighty":-2.041984,"marketCap":432362038},{"date":"2022-04-01","current":-7.080776,"twenty":-6.15825,"median":-2.850472,"eighty":-2.041984,"marketCap":413637698},{"date":"2022-04-08","current":-6.96422,"twenty":-6.180751,"median":-2.853843,"eighty":-2.041984,"marketCap":406828847},{"date":"2022-04-14","current":-7.395477,"twenty":-6.19313,"median":-2.860806,"eighty":-2.041984,"marketCap":432021595},{"date":"2022-04-22","current":-7.290577,"twenty":-6.210376,"median":-2.860806,"eighty":-2.041984,"marketCap":425893630},{"date":"2022-04-29","current":-6.585969,"twenty":-6.244501,"median":-2.860806,"eighty":-2.041984,"marketCap":384732546},{"date":"2022-05-06","current":-5.646366,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":378944534},{"date":"2022-05-13","current":-5.017301,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":336726095},{"date":"2022-05-20","current":-4.824523,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":323788187},{"date":"2022-05-27","current":-4.915839,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":329916670},{"date":"2022-06-03","current":-4.59116,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":308126508},{"date":"2022-06-10","current":-4.017899,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":269653253},{"date":"2022-06-17","current":-4.007753,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":268972311},{"date":"2022-06-24","current":-3.678001,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":246841678},{"date":"2022-07-01","current":-3.931656,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":263865242},{"date":"2022-07-08","current":-4.185311,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":280888806},{"date":"2022-07-15","current":-5.027447,"twenty":-6.277913,"median":-2.871843,"eighty":-2.041297,"marketCap":337407038},{"date":"2022-07-22","current":-5.428222,"twenty":-6.277913,"median":-2.876614,"eighty":-2.041297,"marketCap":364304269},{"date":"2022-07-29","current":-4.631745,"twenty":-6.277913,"median":-2.897069,"eighty":-2.041297,"marketCap":310850278},{"date":"2022-08-05","current":-4.689345,"twenty":-6.277913,"median":-2.902765,"eighty":-2.041297,"marketCap":358777096},{"date":"2022-08-12","current":-4.947637,"twenty":-6.277913,"median":-2.918529,"eighty":-2.041297,"marketCap":378538797},{"date":"2022-08-19","current":-4.680438,"twenty":-6.277913,"median":-2.955067,"eighty":-2.041297,"marketCap":358095658},{"date":"2022-08-26","current":-4.578012,"twenty":-6.277913,"median":-2.981219,"eighty":-2.041297,"marketCap":350259121},{"date":"2022-09-02","current":-4.123773,"twenty":-6.277913,"median":-3.01561,"eighty":-2.041297,"marketCap":315505784},{"date":"2022-09-09","current":-3.990174,"twenty":-6.277913,"median":-3.047288,"eighty":-2.041297,"marketCap":305284215},{"date":"2022-09-16","current":-3.638389,"twenty":-6.277913,"median":-3.074739,"eighty":-2.041297,"marketCap":278369506},{"date":"2022-09-23","current":-3.206414,"twenty":-6.277913,"median":-3.090207,"eighty":-2.041297,"marketCap":245319516},{"date":"2022-09-30","current":-3.522602,"twenty":-6.277913,"median":-3.110217,"eighty":-2.041297,"marketCap":269510746},{"date":"2022-10-07","current":-2.743265,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":209884474},{"date":"2022-10-14","current":-2.493877,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":190804068},{"date":"2022-10-21","current":-2.596305,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":198640663},{"date":"2022-10-28","current":-2.444891,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":187056130},{"date":"2022-11-04","current":-2.291539,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":179276232},{"date":"2022-11-11","current":-2.017077,"twenty":-6.277913,"median":-3.117347,"eighty":-2.037196,"marketCap":157803984},{"date":"2022-11-18","current":-1.568353,"twenty":-6.277913,"median":-3.117347,"eighty":-2.028584,"marketCap":122698562},{"date":"2022-11-25","current":-1.44637,"twenty":-6.277913,"median":-3.117347,"eighty":-2.028584,"marketCap":113155340},{"date":"2022-12-02","current":-1.476866,"twenty":-6.277913,"median":-3.117347,"eighty":-2.020056,"marketCap":115541146},{"date":"2022-12-09","current":-1.267752,"twenty":-6.277913,"median":-3.117347,"eighty":-2.016865,"marketCap":99181337},{"date":"2022-12-16","current":-1.076065,"twenty":-6.277913,"median":-3.117347,"eighty":-2.005257,"marketCap":84184846},{"date":"2022-12-23","current":-1.259039,"twenty":-6.277913,"median":-3.117347,"eighty":-1.998555,"marketCap":98499679},{"date":"2022-12-30","current":-1.524788,"twenty":-6.277913,"median":-3.117347,"eighty":-1.991624,"marketCap":119290269},{"date":"2023-01-06","current":-1.420231,"twenty":-6.277913,"median":-3.117347,"eighty":-1.975507,"marketCap":111110364},{"date":"2023-01-13","current":-2.195695,"twenty":-6.277913,"median":-3.117347,"eighty":-1.963772,"marketCap":171777987},{"date":"2023-01-20","current":-1.834102,"twenty":-6.277913,"median":-3.117347,"eighty":-1.951722,"marketCap":143489152},{"date":"2023-01-27","current":-2.060642,"twenty":-6.277913,"median":-3.110217,"eighty":-1.94839,"marketCap":161212277},{"date":"2023-02-03","current":-2.021433,"twenty":-6.277913,"median":-3.099225,"eighty":-1.94839,"marketCap":158144813},{"date":"2023-02-10","current":-1.768754,"twenty":-6.277913,"median":-3.099225,"eighty":-1.939746,"marketCap":138376712},{"date":"2023-02-17","current":-1.503005,"twenty":-6.277913,"median":-3.099225,"eighty":-1.928219,"marketCap":117586122},{"date":"2023-02-24","current":-1.428944,"twenty":-6.277913,"median":-3.099225,"eighty":-1.918005,"marketCap":111792023},{"date":"2023-03-03","current":-1.086611,"twenty":-6.277913,"median":-3.099225,"eighty":-1.903097,"marketCap":111110364},{"date":"2023-03-10","current":-0.811808,"twenty":-6.277913,"median":-3.099225,"eighty":-1.876527,"marketCap":83010660},{"date":"2023-03-17","current":-0.788326,"twenty":-6.277913,"median":-3.099225,"eighty":-1.862926,"marketCap":80609526},{"date":"2023-03-24","current":-0.764844,"twenty":-6.277913,"median":-3.099225,"eighty":-1.844212,"marketCap":78208391},{"date":"2023-03-31","current":-0.986247,"twenty":-6.277913,"median":-3.098122,"eighty":-1.833959,"marketCap":100847662},{"date":"2023-04-06","current":-1.014761,"twenty":-6.277913,"median":-3.099225,"eighty":-1.830785,"marketCap":103763326},{"date":"2023-04-14","current":-1.298223,"twenty":-6.277913,"median":-3.096321,"eighty":-1.818062,"marketCap":132748453},{"date":"2023-04-21","current":-1.905402,"twenty":-6.277913,"median":-3.074739,"eighty":-1.806764,"marketCap":194834939},{"date":"2023-04-28","current":-2.101645,"twenty":-6.277913,"median":-3.057645,"eighty":-1.806764,"marketCap":214901566},{"date":"2023-05-05","current":-2.270232,"twenty":-6.25452,"median":-3.0294,"eighty":-1.806764,"marketCap":232567058},{"date":"2023-05-12","current":-2.136295,"twenty":-6.25452,"median":-3.000653,"eighty":-1.806764,"marketCap":218846287},{"date":"2023-05-19","current":-2.052584,"twenty":-6.25452,"median":-2.918529,"eighty":-1.806764,"marketCap":210270806},{"date":"2023-05-26","current":-1.985615,"twenty":-6.25452,"median":-2.89721,"eighty":-1.806764,"marketCap":203410421},{"date":"2023-06-02","current":-1.995661,"twenty":-6.25452,"median":-2.88216,"eighty":-1.806764,"marketCap":204439478},{"date":"2023-06-09","current":-2.035842,"twenty":-6.25452,"median":-2.865856,"eighty":-1.806764,"marketCap":208555710},{"date":"2023-06-16","current":-2.27358,"twenty":-6.25452,"median":-2.836384,"eighty":-1.806764,"marketCap":232910077},{"date":"2023-06-23","current":-2.08272,"twenty":-6.25953,"median":-2.815898,"eighty":-1.806567,"marketCap":213357979},{"date":"2023-06-30","current":-2.752405,"twenty":-6.264539,"median":-2.79725,"eighty":-1.80637,"marketCap":281961831},{"date":"2023-07-07","current":-2.882993,"twenty":-6.219784,"median":-2.79725,"eighty":-1.80637,"marketCap":295339582},{"date":"2023-07-14","current":-3.63304,"twenty":-6.19313,"median":-2.79725,"eighty":-1.80637,"marketCap":372175897},{"date":"2023-07-21","current":-3.95114,"twenty":-6.180681,"median":-2.79725,"eighty":-1.80637,"marketCap":404762726},{"date":"2023-07-28","current":-3.515845,"twenty":-6.158749,"median":-2.79725,"eighty":-1.80637,"marketCap":360170223},{"date":"2023-08-04","current":-4.05643,"twenty":-6.148902,"median":-2.79725,"eighty":-1.8052,"marketCap":429803132},{"date":"2023-08-11","current":-4.629056,"twenty":-6.137112,"median":-2.79725,"eighty":-1.8052,"marketCap":490476296},{"date":"2023-08-18","current":-4.361614,"twenty":-6.101011,"median":-2.79725,"eighty":-1.8052,"marketCap":462139221},{"date":"2023-08-25","current":-3.800317,"twenty":-6.098107,"median":-2.79725,"eighty":-1.8052,"marketCap":402666346},{"date":"2023-09-01","current":-3.272036,"twenty":-6.067271,"median":-2.79725,"eighty":-1.8052,"marketCap":346691876},{"date":"2023-09-08","current":-3.321563,"twenty":-6.026618,"median":-2.79725,"eighty":-1.8052,"marketCap":351939482},{"date":"2023-09-15","current":-3.631927,"twenty":-5.954331,"median":-2.79725,"eighty":-1.8052,"marketCap":384824484},{"date":"2023-09-22","current":-2.756963,"twenty":-5.954331,"median":-2.790917,"eighty":-1.8052,"marketCap":292116767},{"date":"2023-09-29","current":-2.641402,"twenty":-5.954331,"median":-2.778602,"eighty":-1.8052,"marketCap":279872352},{"date":"2023-10-06","current":-2.793282,"twenty":-5.954331,"median":-2.768311,"eighty":-1.8052,"marketCap":295965012},{"date":"2023-10-13","current":-2.674419,"twenty":-5.954331,"median":-2.767265,"eighty":-1.8052,"marketCap":283370756},{"date":"2023-10-20","current":-2.476314,"twenty":-5.954331,"median":-2.759953,"eighty":-1.8052,"marketCap":262380330},{"date":"2023-10-27","current":-2.039467,"twenty":-5.962331,"median":-2.756201,"eighty":-1.801691,"marketCap":216093723},{"date":"2023-11-03","current":-2.570254,"twenty":-5.962331,"median":-2.752288,"eighty":-1.801691,"marketCap":257405759},{"date":"2023-11-10","current":-2.326979,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":233042251},{"date":"2023-11-17","current":-2.178898,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":218212289},{"date":"2023-11-24","current":-2.164795,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":216799912},{"date":"2023-12-01","current":-2.203578,"twenty":-5.962331,"median":-2.74344,"eighty":-1.801691,"marketCap":220683950},{"date":"2023-12-08","current":-9.955568,"twenty":-6.049293,"median":-2.752172,"eighty":-1.802861,"marketCap":997030242},{"date":"2023-12-15","current":-9.574831,"twenty":-6.092369,"median":-2.75544,"eighty":-1.802861,"marketCap":958900191},{"date":"2023-12-22","current":-9.77225,"twenty":-6.109725,"median":-2.759953,"eighty":-1.802861,"marketCap":978671329},{"date":"2023-12-29","current":-11.074277,"twenty":-6.140987,"median":-2.764196,"eighty":-1.806567,"marketCap":1109066691},{"date":"2024-01-05","current":-9.368011,"twenty":-6.14956,"median":-2.778602,"eighty":-1.80637,"marketCap":938187570},{"date":"2024-01-12","current":-9.570131,"twenty":-6.168114,"median":-2.793282,"eighty":-1.80637,"marketCap":958429449},{"date":"2024-01-19","current":-10.745245,"twenty":-6.181032,"median":-2.79725,"eighty":-1.8052,"marketCap":1076114794},{"date":"2024-01-26","current":-11.704138,"twenty":-6.200408,"median":-2.804116,"eighty":-1.80637,"marketCap":1172146036},{"date":"2024-02-02","current":-13.401003,"twenty":-6.254636,"median":-2.834547,"eighty":-1.80637,"marketCap":1342083674},{"date":"2024-02-09","current":-13.687731,"twenty":-6.30708,"median":-2.853195,"eighty":-1.80637,"marketCap":1370798898},{"date":"2024-02-16","current":-13.668929,"twenty":-6.37565,"median":-2.853195,"eighty":-1.80637,"marketCap":1368915933},{"date":"2024-02-23","current":-12.268193,"twenty":-6.417185,"median":-2.853195,"eighty":-1.80637,"marketCap":1228635001},{"date":"2024-03-01","current":-12.789944,"twenty":-6.540499,"median":-2.856467,"eighty":-1.806567,"marketCap":1280887294},{"date":"2024-03-08","current":-16.829528,"twenty":-6.600791,"median":-2.864789,"eighty":-1.806567,"marketCap":1191446432},{"date":"2024-03-15","current":-15.302231,"twenty":-6.677113,"median":-2.871843,"eighty":-1.806567,"marketCap":1083321418},{"date":"2024-03-22","current":-16.48474,"twenty":-6.761591,"median":-2.887382,"eighty":-1.806567,"marketCap":1167037148},{"date":"2024-03-28","current":-14.647627,"twenty":-6.81781,"median":-2.892586,"eighty":-1.806567,"marketCap":1036978781},{"date":"2024-04-05","current":-14.18307,"twenty":-6.857077,"median":-2.918529,"eighty":-1.80637,"marketCap":1004090458},{"date":"2024-04-12","current":-16.111686,"twenty":-6.901762,"median":-3.019122,"eighty":-1.80637,"marketCap":1140626828},{"date":"2024-04-19","current":-12.317803,"twenty":-6.964065,"median":-3.050414,"eighty":-1.807354,"marketCap":872038860},{"date":"2024-04-26","current":-11.374611,"twenty":-6.977129,"median":-3.092915,"eighty":-1.807507,"marketCap":805265598},{"date":"2024-05-03","current":-14.669933,"twenty":-6.99966,"median":-3.108194,"eighty":-1.807507,"marketCap":1038557911},{"date":"2024-05-10","current":-8.362276,"twenty":-7.014797,"median":-3.172728,"eighty":-1.811775,"marketCap":659909031},{"date":"2024-05-17","current":-8.263275,"twenty":-7.045704,"median":-3.193664,"eighty":-1.811775,"marketCap":652096375},{"date":"2024-05-24","current":-7.332667,"twenty":-7.080776,"median":-3.232956,"eighty":-1.817369,"marketCap":578657406},{"date":"2024-05-31","current":-7.095065,"twenty":-7.101547,"median":-3.286694,"eighty":-1.83021,"marketCap":559907031},{"date":"2024-06-07","current":-6.118256,"twenty":-7.101547,"median":-3.330137,"eighty":-1.834973,"marketCap":482822156},{"date":"2024-06-14","current":-6.131456,"twenty":-7.102515,"median":-3.412645,"eighty":-1.845001,"marketCap":483863843},{"date":"2024-06-21","current":-5.385649,"twenty":-7.102515,"median":-3.462472,"eighty":-1.863418,"marketCap":425008500},{"date":"2024-06-28","current":-5.775053,"twenty":-7.102515,"median":-3.473443,"eighty":-1.885785,"marketCap":455738281},{"date":"2024-07-05","current":-5.689252,"twenty":-7.102515,"median":-3.509148,"eighty":-1.903349,"marketCap":448967312},{"date":"2024-07-12","current":-6.54066,"twenty":-7.102515,"median":-3.561832,"eighty":-1.919277,"marketCap":516156156},{"date":"2024-07-15","current":-6.817862,"twenty":-7.102515,"median":-3.561832,"eighty":-1.920686,"marketCap":538031593},{"date":"2024-08-02","current":-6.025855,"twenty":-7.124873,"median":-3.608452,"eighty":-1.963141,"marketCap":475530343},{"date":"2024-08-09","current":-5.503143,"twenty":-7.124873,"median":-3.632484,"eighty":-1.96681,"marketCap":477788393},{"date":"2024-08-16","current":-5.054645,"twenty":-7.124873,"median":-3.645064,"eighty":-1.980482,"marketCap":438849322},{"date":"2024-08-23","current":-5.547781,"twenty":-7.124873,"median":-3.698817,"eighty":-1.980482,"marketCap":481663890},{"date":"2024-08-30","current":-5.375183,"twenty":-7.124873,"median":-3.810182,"eighty":-1.980482,"marketCap":466678791},{"date":"2024-09-06","current":-4.968346,"twenty":-7.124873,"median":-3.83418,"eighty":-1.980482,"marketCap":431356772},{"date":"2024-09-13","current":-5.473811,"twenty":-7.124873,"median":-3.903238,"eighty":-1.980482,"marketCap":475241704},{"date":"2024-09-20","current":-5.658737,"twenty":-7.124873,"median":-3.951544,"eighty":-1.980482,"marketCap":491297167},{"date":"2024-09-27","current":-4.97451,"twenty":-7.124873,"median":-3.986281,"eighty":-1.980482,"marketCap":431891954},{"date":"2024-10-04","current":-5.159436,"twenty":-7.124873,"median":-4.012982,"eighty":-1.980482,"marketCap":447947417},{"date":"2024-10-11","current":-5.079302,"twenty":-7.124873,"median":-4.052753,"eighty":-1.980482,"marketCap":440990050},{"date":"2024-10-18","current":-6.873084,"twenty":-7.124873,"median":-4.083441,"eighty":-1.980482,"marketCap":596728041},{"date":"2024-10-25","current":-5.892976,"twenty":-7.124873,"median":-4.137591,"eighty":-1.980482,"marketCap":511634087},{"date":"2024-10-31","current":-8.74412,"twenty":-7.137898,"median":-4.196959,"eighty":-1.980482,"marketCap":759173235},{"date":"2024-11-08","current":-7.626837,"twenty":-7.20923,"median":-4.361614,"eighty":-1.97961,"marketCap":789911501},{"date":"2024-11-15","current":-7.106109,"twenty":-7.272765,"median":-4.416406,"eighty":-1.97961,"marketCap":735979669},{"date":"2024-11-22","current":-5.656435,"twenty":-7.272765,"median":-4.456923,"eighty":-1.97961,"marketCap":585837010},{"date":"2024-11-29","current":-5.995144,"twenty":-7.272765,"median":-4.545502,"eighty":-1.97961,"marketCap":620917070},{"date":"2024-12-06","current":-5.527726,"twenty":-7.272765,"median":-4.586087,"eighty":-1.97961,"marketCap":572506587},{"date":"2024-12-13","current":-5.378694,"twenty":-7.272765,"median":-4.621598,"eighty":-1.97961,"marketCap":557071360},{"date":"2024-12-20","current":-4.823212,"twenty":-7.272765,"median":-4.654737,"eighty":-1.97961,"marketCap":499540061},{"date":"2024-12-27","current":-5.134824,"twenty":-7.272765,"median":-4.680438,"eighty":-1.97961,"marketCap":531813717},{"date":"2025-01-03","current":-5.439662,"twenty":-7.272765,"median":-4.688488,"eighty":-1.97961,"marketCap":563385771},{"date":"2025-01-10","current":-6.171273,"twenty":-7.274134,"median":-4.721011,"eighty":-1.978739,"marketCap":639158702},{"date":"2025-01-17","current":-4.924825,"twenty":-7.274134,"median":-4.757117,"eighty":-1.978739,"marketCap":510064079},{"date":"2025-01-24","current":-5.974822,"twenty":-7.274134,"median":-4.81202,"eighty":-1.978739,"marketCap":618812267},{"date":"2025-01-31","current":-5.45321,"twenty":-7.274134,"median":-4.825842,"eighty":-1.978739,"marketCap":564788974},{"date":"2025-02-07","current":-4.484503,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":464460001},{"date":"2025-02-14","current":-4.274504,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":442710363},{"date":"2025-02-21","current":-4.301601,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":445516768},{"date":"2025-02-28","current":-4.22031,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":437097553},{"date":"2025-03-07","current":-3.581647,"twenty":-7.275504,"median":-4.857083,"eighty":-1.977868,"marketCap":468730143},{"date":"2025-03-14","current":-3.586899,"twenty":-7.275504,"median":-4.857083,"eighty":-1.977868,"marketCap":469417430},{"date":"2025-03-21","current":-3.203526,"twenty":-7.275504,"median":-4.857083,"eighty":-1.982224,"marketCap":419245436},{"date":"2025-03-28","current":-3.103744,"twenty":-7.275504,"median":-4.857083,"eighty":-1.982224,"marketCap":406186971},{"date":"2025-04-04","current":-2.620589,"twenty":-7.275504,"median":-4.857083,"eighty":-1.986581,"marketCap":342956512},{"date":"2025-04-11","current":-2.520807,"twenty":-7.274134,"median":-4.853805,"eighty":-1.998664,"marketCap":329898048},{"date":"2025-04-17","current":-2.914683,"twenty":-7.274134,"median":-4.853805,"eighty":-2.003697,"marketCap":381444618},{"date":"2025-04-25","current":-3.4346,"twenty":-7.275504,"median":-4.857083,"eighty":-2.020056,"marketCap":449486090},{"date":"2025-05-02","current":-3.744449,"twenty":-7.275504,"median":-4.857083,"eighty":-2.020056,"marketCap":490036058},{"date":"2025-05-09","current":-2.859698,"twenty":-7.275504,"median":-4.857083,"eighty":-2.021433,"marketCap":419749277},{"date":"2025-05-13","current":-2.742512,"twenty":-7.275504,"median":-4.857083,"eighty":-2.021433,"marketCap":402548655}],"updateTime":1747226299922}}}